• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Early Prognostic Markers Predict Bioprosthetic Mitral Valve Dysfunction in Younger Patients

by
November 17, 2026
in Health
Reading Time: 3 mins read
0
Early Prognostic Markers Predict Bioprosthetic Mitral Valve Dysfunction in Younger Patients

Early Prognostic Markers Predict Bioprosthetic Mitral Valve Dysfunction in Younger Patients

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A retrospective cohort study involving 238 patients aged 70 years or younger has identified four early postoperative markers that significantly predict bioprosthetic mitral valve dysfunction following valve replacement surgery. Researchers identified that advanced New York Heart Association (NYHA) functional class, elevated pulmonary artery systolic pressure (PASP), higher mean transmitral gradient, and reduced effective orifice area (EOA) are independently associated with long-term dysfunction of the prosthetic valve. This study, published in the Journal of Cardiothoracic Surgery, highlights the critical need for refined risk stratification in this younger patient demographic, as the prevalence of bioprosthetic mitral valve replacement in individuals under 70 continues to increase despite traditional clinical recommendations favoring older patients for such procedures.

The study spanned a 13-year period from January 2009 to December 2022, tracking outcomes in a cohort that provided a median echocardiographic follow-up of 166.2 months, with an interquartile range of 77.8 to 175.5 months. Investigators defined mitral valve dysfunction as the emergence or progression of prosthetic morphological abnormalities accompanied by hemodynamic deterioration following the initial 1 to 3-month postoperative reference examination.

To isolate these predictive factors, the research team employed LASSO-selected variables within a multivariable cause-specific Cox model. The resulting hazard ratios provided clear evidence of the prognostic power of the identified clinical and echocardiographic variables. Patients presenting with an NYHA functional class of III or higher faced a hazard ratio of 1.89 for developing valve dysfunction compared to those with lower classifications.

The echocardiographic parameters similarly demonstrated strong predictive value. Every 1 mmHg increase in the mean transmitral gradient was associated with a 1.31 hazard ratio for developing dysfunction.

By incorporating these four independent markers, the researchers developed a nomogram designed to assist clinicians in postoperative risk stratification. Internal validation, conducted using 1,000 selection-aware bootstrap resamples, indicated that the model possesses good discrimination capabilities. The optimism-corrected C-index was reported as 0.791, with a 95% confidence interval ranging from 0.740 to 0.840. The model also demonstrated strong predictive accuracy over time, with corrected area under the curve values of 0.842 and 0.809 at 7 and 10 years, respectively, suggesting reliable utility for long-term patient monitoring.

The research emphasizes the clinical significance of distinguishing risk groups through these measurements. In comparisons performed using competing-risk analysis, the nomogram-based risk groups demonstrated significantly different cumulative incidences of valve dysfunction, with Gray’s P-value reported at less than 0.001.

Despite these findings, the authors explicitly state that while the nomogram provides a promising framework for postoperative management, external validation is a mandatory next step before it can be applied in routine clinical practice. As a retrospective study, the findings are subject to the inherent limitations of patient selection and non-randomized data, which could affect generalizability to different patient populations or surgical environments.

Ultimately, this research provides a data-driven foundation for addressing the specific challenges of managing younger patients after bioprosthetic mitral valve replacement.

Subject of Research: Prognostic factors for bioprosthetic mitral valve dysfunction in patients aged ≤ 70.

Article Title: Early postoperative prognostic markers of bioprosthetic mitral valve dysfunction in patients aged ≤ 70 years: a retrospective cohort study

Article References: Huang, H.-Q., Li, C.-L., Liu, X.-D., Fan, R., Ye, M., Liu, Y.-Q., Liu, D.-H., Lei, Y.-Y., Yao, F.-J., & Li, W. (2026). Early postoperative prognostic markers of bioprosthetic mitral valve dysfunction in patients aged ≤ 70 years: a retrospective cohort study. Journal of Cardiothoracic Surgery. https://doi.org/10.1186/s13019-026-04787-2

Image Credits: AI Generated

DOI: 10.1186/s13019-026-04787-2

Keywords: cardiology, mitral valve replacement, bioprosthetic valves, valve dysfunction, heart surgery, prognostic markers, echocardiography, cardiac hemodynamics, NYHA classification, pulmonary artery pressure, transmitral gradient, effective orifice area, retrospective study, risk stratification, bioprosthetics, cardiac outcomes

News Source: Ophelia Keating. (November 17, 2026). Early Prognostic Markers Predict Bioprosthetic Mitral Valve Dysfunction in Younger Patients. Scienmag.

Tags: bioprosthetic valvesbioprostheticscardiac hemodynamicscardiac outcomesCardiologyechocardiographyeffective orifice areaheart surgerymitral valve replacementNYHA classificationprognostic markerspulmonary artery pressureRetrospective studyrisk stratificationtransmitral gradientvalve dysfunction
Share12Tweet7Share2ShareShareShare1

Related Posts

Study Links Specific Dietary Patterns to Atherosclerotic Cardiovascular Disease in Upper Egypt

Study Links Specific Dietary Patterns to Atherosclerotic Cardiovascular Disease in Upper Egypt

November 19, 2026
PCR Testing Shows Malaria Prevalence Rose in Remote Peruvian Amazon Communities

PCR Testing Shows Malaria Prevalence Rose in Remote Peruvian Amazon Communities

November 19, 2026

Low HLA-A Expression and NK Cells Linked to Pediatric HIV Remission

November 19, 2026

Siamese Neural Network Classifies Neuromuscular Disorders From Muscle Ultrasound Scans

November 19, 2026

POPULAR NEWS

  • Somatic Symptom Burden in Oral Health Clinic Patients Shifted Modestly Across Pandemic

    Somatic Symptom Burden in Oral Health Clinic Patients Shifted Modestly Across Pandemic

    29 shares
    Share 12 Tweet 7
  • Multicenter ICU Study Identifies Nurse Knowledge Gaps in Pneumonia Prevention

    29 shares
    Share 12 Tweet 7
  • Study Finds One-Third of Ethiopian Neuropsychiatric Patients Exhibit Harmful Alcohol Use

    29 shares
    Share 12 Tweet 7
  • Low-Dose Epidural Analgesia Modestly Lengthens Labor Stages in Low-Risk Women

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Study Links Specific Dietary Patterns to Atherosclerotic Cardiovascular Disease in Upper Egypt

PCR Testing Shows Malaria Prevalence Rose in Remote Peruvian Amazon Communities

Low HLA-A Expression and NK Cells Linked to Pediatric HIV Remission

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.